Insulin Like Growth Factor 2 (IGF- 2) Inhibitors - Pipeline Insights, 2016


#532854

60pages

DelveInsight

$ 1250

In Stock

SUMMARY
DelveInsights, Insulin Like Growth Factor 2 (IGF-2) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Insulin Like Growth Factor 2 (IGF-2) Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsights Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Insulin Like Growth Factor 2 (IGF-2) Inhibitors. DelveInsights Report also assesses the Insulin Like Growth Factor 2 (IGF-2) Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Scope